Dian Diagnostics Group Co.,Ltd. (SHE:300244)
China · Delayed Price · Currency is CNY 25.01
+0.28 (1.13%)
Feb 4, 2026, 2:45 PM CST
Dian Diagnostics Group Revenue
Dian Diagnostics Group had revenue of 2.63B CNY in the quarter ending September 30, 2025, a decrease of -13.52%. This brings the company's revenue in the last twelve months to 10.50B, down -15.12% year-over-year. In the year 2024, Dian Diagnostics Group had annual revenue of 12.20B, down -9.04%.
Revenue (ttm)
10.50B
Revenue Growth
-15.12%
P/S Ratio
1.44
Revenue / Employee
1.20M
Employees
8,773
Market Cap
15.11B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 12.20B | -1.21B | -9.04% |
| Dec 31, 2023 | 13.41B | -6.87B | -33.89% |
| Jan 1, 2023 | 20.28B | 7.20B | 55.03% |
| Jan 1, 2022 | 13.08B | 2.43B | 22.85% |
| Dec 31, 2020 | 10.65B | 2.20B | 25.98% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Runda Medical Technology | 7.40B |
| Guangzhou Kingmed Diagnostics Group | 6.11B |
| BGI Genomics | 3.71B |
| Maccura Biotechnology Co.Ltd | 2.21B |
| Joinn Laboratories(China)Co.,Ltd. | 1.67B |
| Beijing Strong Biotechnologies,Inc. | 1.43B |
| Thalys Medical Technology Group | 1.25B |
| Amoy Diagnostics | 1.13B |